Jennifer A H Bell1, Lynda G Balneaves. 1. Psychosocial Oncology and Palliative Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada, Jennifer.Bell2@uhn.ca.
Abstract
PURPOSE: Oncology clinical trials are necessary for the improvement of patient care as they have the ability to confirm the efficacy and safety of novel cancer treatments and in so doing, contribute to a solid evidence base on which practitioners and patients can make informed treatment decisions. However, only 3-5 % of adult cancer patients enroll in clinical trials. Lack of participation compromises the success of clinical trials and squanders an opportunity for improving patient outcomes. This literature review summarizes the factors and contexts that influence cancer patient decision making related to clinical trial participation. METHODS: An integrative review was undertaken within PubMed, CINAHL, and EMBASE databases for articles written between 1995 and 2012 and archived under relevant keywords. Articles selected were data-based, written in English, and limited to adult cancer patients. RESULTS: In the 51 articles reviewed, three main types of factors were identified that influence cancer patients' decision making about participation in clinical trials: personal, social, and system factors. Subthemes included patients' trust in their physician and the research process, undue influence within the patient-physician relationship, and systemic social inequalities. How these factors interact and influence patients' decision-making process and relational autonomy, however, is insufficiently understood. CONCLUSIONS: Future research is needed to further elucidate the sociopolitical barriers and facilitators of clinical trial participation and to enhance ethical practice within clinical trial enrolment. This research will inform targeted education and support interventions to foster patients' relational autonomy in the decision-making process and potentially improve clinical trial participation rates.
PURPOSE: Oncology clinical trials are necessary for the improvement of patient care as they have the ability to confirm the efficacy and safety of novel cancer treatments and in so doing, contribute to a solid evidence base on which practitioners and patients can make informed treatment decisions. However, only 3-5 % of adult cancerpatients enroll in clinical trials. Lack of participation compromises the success of clinical trials and squanders an opportunity for improving patient outcomes. This literature review summarizes the factors and contexts that influence cancerpatient decision making related to clinical trial participation. METHODS: An integrative review was undertaken within PubMed, CINAHL, and EMBASE databases for articles written between 1995 and 2012 and archived under relevant keywords. Articles selected were data-based, written in English, and limited to adult cancerpatients. RESULTS: In the 51 articles reviewed, three main types of factors were identified that influence cancerpatients' decision making about participation in clinical trials: personal, social, and system factors. Subthemes included patients' trust in their physician and the research process, undue influence within the patient-physician relationship, and systemic social inequalities. How these factors interact and influence patients' decision-making process and relational autonomy, however, is insufficiently understood. CONCLUSIONS: Future research is needed to further elucidate the sociopolitical barriers and facilitators of clinical trial participation and to enhance ethical practice within clinical trial enrolment. This research will inform targeted education and support interventions to foster patients' relational autonomy in the decision-making process and potentially improve clinical trial participation rates.
Authors: Anjali S Advani; Benjamin Atkeson; Carrie L Brown; Bercedis L Peterson; Laura Fish; Jeffrey L Johnson; Jon P Gockerman; Marc Gautier Journal: Cancer Date: 2003-03-15 Impact factor: 6.860
Authors: Warren B Sateren; Edward L Trimble; Jeffrey Abrams; Otis Brawley; Nancy Breen; Leslie Ford; Mary McCabe; Richard Kaplan; Malcolm Smith; Richard Ungerleider; Michaele C Christian Journal: J Clin Oncol Date: 2002-04-15 Impact factor: 44.544
Authors: H A Tejeda; S B Green; E L Trimble; L Ford; J L High; R S Ungerleider; M A Friedman; O W Brawley Journal: J Natl Cancer Inst Date: 1996-06-19 Impact factor: 13.506
Authors: Salman Siddiqui; Loren C Denlinger; Stephen J Fowler; Praveen Akuthota; Dominick E Shaw; Liam G Heaney; Louise Brown; Mario Castro; Tonya A Winders; Monica Kraft; Scott Wagers; Michael C Peters; Ian D Pavord; Samantha Walker; Nizar N Jarjour Journal: Am J Respir Crit Care Med Date: 2019-04-01 Impact factor: 21.405
Authors: G Montalban-Bravo; X Huang; K Naqvi; E Jabbour; G Borthakur; C D DiNardo; N Pemmaraju; J Cortes; S Verstovsek; T Kadia; N Daver; W Wierda; Y Alvarado; M Konopleva; F Ravandi; Z Estrov; N Jain; A Alfonso; M Brandt; T Sneed; H-C Chen; H Yang; C Bueso-Ramos; S Pierce; E Estey; Z Bohannan; H M Kantarjian; G Garcia-Manero Journal: Leukemia Date: 2016-10-31 Impact factor: 11.528
Authors: Goldy C George; Adrianna Buford; Kenneth Hess; Sarina A Piha-Paul; Ralph Zinner; Vivek Subbiah; Christina Hinojosa; Charles S Cleeland; Funda Meric-Bernstam; Elmer V Bernstam; David S Hong Journal: JCO Clin Cancer Inform Date: 2018-12
Authors: Betty R Ferrell; Carly L Paterson; Mark T Hughes; Vincent Chung; Marianna Koczywas; Thomas J Smith Journal: J Palliat Med Date: 2017-06-13 Impact factor: 2.947
Authors: Samilia Obeng-Gyasi; Sheetal M Kircher; Kelsey P Lipking; Benjamin J Keele; Al B Benson; Lynne I Wagner; Ruth C Carlos Journal: Cancer Date: 2019-06-28 Impact factor: 6.860
Authors: Ryan W Huey; Goldy C George; Penny Phillips; Revenda White; Siqing Fu; Filip Janku; Daniel D Karp; Aung Naing; Sarina Piha-Paul; Vivek Subbiah; Apostolia M Tsimberidou; Shubham Pant; Timothy A Yap; Jordi Rodon; Funda Meric-Bernstam; Ya-Chen Tina Shih; David S Hong Journal: Oncologist Date: 2021-04-21